Global Robotic Surgery for Endometrial Cancer Market, By Robotic Surgery Component (Robotic Surgery System, Maintenance Service), End- Users (Hospitals, Research Centers, Laboratories, Others), Surgery Type (Cryosurgery, Laser Surgery, Simple Hysterectomy, Radical Hysterectomy, Trachelectomy, Others) – Industry Trends and Forecast to 2029.
Robotic surgery for Endometrial Cancer Market Analysis and Size
The market for robotic surgery for endometrial cancer is expected to grow in the forecast period. The market is grow due to a number of additional factors, including increasing public awareness of the diagnosis, prevention, and treatment of the disease, advancements in the healthcare sector, favourable reimbursement policies, and rising adoption of robotic surgery.
Data Bridge Market Research analyses that robotic surgery for endometrial cancer market which was USD 5406.18 million in 2021, would rocket up to USD 15206.48 million by 2029, and is expected to undergo a CAGR of 13.80% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Robotic surgery for Endometrial Cancer Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Robotic Surgery Component (Robotic Surgery System, Maintenance Service), End- Users (Hospitals, Research Centers, Laboratories, Others), Surgery Type (Cryosurgery, Laser Surgery, Simple Hysterectomy, Radical Hysterectomy, Trachelectomy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Intuitive Surgical Inc (U.S.), Stryker (U.S.), Medrobotics Corporation (U.S), Johnson & Johnson Private Limited (U.S.), Globus medical (U.S.), NuVasive Inc. (U.S.), Smith + Nephew (U.K.), Titan Medical Inc (Canada), TransEnterix Inc (U.S.), University of Pittsburgh Medical Center (U.S.), Mazor Robotics (Israel), Auris Health Inc. (U.S.), Corindus Inc. (U.S.), Renishaw plc (U.K.)
|
|
Market Opportunities
|
|
Market Definition
Robotic surgery for endometrial cancer has less blood loss, shorter hospital stays, and less postoperative complications compared to laparotomies. Robotic technologic advantages over laparoscopic technique are most pronounced in obese patients. The shorter learning curve may explain the greater utilization of the robotic technique. Robotic surgery will continue as a mainstay in the treatment of uterine cancers as we become more efficient and cost conscious while maintaining the high quality outcomes that have been reported.
Robotic surgery for Endometrial Cancer Market Dynamics
Drivers
- Rise in public awareness
The market is anticipated to develop faster as endometrial cancer cases rise. During the forecast period of 2022 to 2029, the market for robotic surgery for endometrial cancer is anticipated to grow due to a number of additional factors, including rising public awareness of the diagnosis, prevention, and treatment of the disease, advancements in the healthcare sector, favourable reimbursement policies, and growing adoption of robotic surgery.
- Minimally Invasive Surgeries
The need for robotic surgery devices used in surgical operations will rise as the popularity of minimally invasive surgery (MIS) increases. Any surgical method that, in contrast to traditional or open surgery utilised for the same purpose, uses only small incisions is referred to as MIS. The popularity of MIS treatments has grown as a result of their many benefits, including quick healing and recovery times, little scarring, little trauma and pain, less blood loss, and a lower risk of infections and problems.
- Technological developments
Medical technological advancements paved the way for the creation of cutting-edge surgical instruments like Da Vinci robotic surgical systems. These tools enable MIS procedures and will propel the market during the forecast period.
Opportunities
- Rise in surgeries
The market for robotic surgery for endometrial cancer is anticipated to rise during the forecast period of 2022 to 2029 due to the rising acceptance of robotic surgery. Furthermore, if endometrial cancer cases rise, there will be more than enough room for the industry to expand.
Restraints/Challenges
- High cost
The high cost of robotic surgery and rising public safety concerns are anticipated to restrain market expansion during the forecast period.
This robotic surgery for endometrial cancer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the robotic surgery for endometrial cancer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Robotic Surgery for Endometrial Cancer Market
The use of micro- and nanorobots in urological surgical operations, the emphasis on the development of affordable robotic surgical systems, and rising MedTech research and development costs are a few prominent themes. The COVID-19 pandemic outbreak in 2020 had a negative effect on the market since numerous government agencies had instructed hospitals to only attend serious cases.
Global Robotic Surgery for Endometrial Cancer Market Scope
The robotic surgery for endometrial cancer market is segmented on the basis of robotic surgery component, end- users, and surgery type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Robotic Surgery Component
- Robotic Surgery System
- Maintenance Service
End- Users
- Hospitals
- Research Centers
- Laboratories
- Others
Surgery Type
- Cryosurgery
- Laser Surgery
- Simple Hysterectomy
- Radical Hysterectomy
- Trachelectomy
- Others
Robotic Surgery for Endometrial Cancer Market Regional Analysis/Insights
The robotic surgery for endometrial cancer market is analysed and market size insights and trends are provided by country, robotic surgery component, end- users, and surgery type as referenced above.
The countries covered in the robotic surgery for endometrial cancer market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the robotic surgery for endometrial cancer market due to the growing number of geriatric population along with adoption of innovative medical technology.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Global robotic surgery for endometrial cancer market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Global robotic surgery for endometrial cancer market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Global robotic surgery for endometrial cancer market. The data is available for historic period 2010-2020.
Competitive Landscape and Robotic Surgery for Endometrial Cancer Market Share Analysis
The robotic surgery for endometrial cancer market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to robotic surgery for endometrial cancer market.
Some of the major players operating in the robotic surgery for endometrial cancer market are:
- Intuitive Surgical Inc (U.S.)
- Stryker (U.S.)
- Medrobotics Corporation (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Globus medical (U.S.)
- NuVasive Inc. (U.S.)
- Smith+Nephew (U.K.)
- Titan Medical Inc (Canada)
- TransEnterix Inc (U.S.)
- University of Pittsburgh Medical Center (U.S.)
- Mazor Robotics (Israel)
- Auris Health Inc. (U.S.)
- Corindus Inc. (U.S.)
- Renishaw plc (U.K.)
SKU-